Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Results From ELM-2, a Ph 2 Study of Odronextamab in Pts With R/R FL"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jose C. Villasboas
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jose C. Villasboas
Login to view comments.
Click here to Login